跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEXITAZ 500 POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
PEXITAZ 500 POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL
Approved
THERAPEUTIC
PEXITAZ 500 POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL
SUN PHARMACEUTICAL INDUSTRIES LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Sep 21, 2018
Approval ID
59bc811f86c95dc9
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
59bc811f86c95dc9
Drug Name
PEXITAZ 500 POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL
Product Name
PEXITAZ 500 POWDER FOR SOLUTION FOR INJECTION 500MG/VIAL
Approval Number
SIN15546P
Approval Date
2018-09-21
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01BA04
Atc Item Name
pemetrexed
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Active Ingredients
Pemetrexed disodium heptahydrate 698.97mg eqv Pemetrexed
500.00 mg/vial
PEMETREXED DISODIUM HEPTAHYDRATE 698.97 MG EQV PEMETREXED
500 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 21, 2018
Approval ID
59bc811f86c95dc9
Type
Therapeutic
Back to HSA Approvals
